Engineering the gut microbiota to treat chronic diseases

被引:0
作者
Noura S. Dosoky
Linda S. May-Zhang
Sean S. Davies
机构
[1] Vanderbilt University,Department of Pharmacology and Division of Clinical Pharmacology
来源
Applied Microbiology and Biotechnology | 2020年 / 104卷
关键词
Gut microbiota; Engineered bacteria; Cancer; Diabetes; Inflammatory bowel disease; Atherosclerosis; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7657 / 7671
页数:14
相关论文
共 804 条
[21]  
Steidler L(2014) as a versatile vehicle for tolerogenic immunotherapy Appl Environ Microbiol 80 869-794
[22]  
Broadway KM(2015)Influence of infection route and virulence factors on colonization of solid tumors by Cytokine. 73 177-5193
[23]  
Denson EAP(2017) serovar Typhimurium Int Immunopharmacol 42 122-1691
[24]  
Jensen RV(2016)Combination bacteriolytic therapy for the treatment of experimental tumors PLoS One 11 e0155338-466
[25]  
Scharf BE(2018)Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing ACS Infect Dis 4 3-240
[26]  
Broadway KM(2019) using a murine model of Crohn’s disease Appl Microbiol Biotechnol 103 6711-824
[27]  
Suh S(2008)A novel interleukin-10 DNA mucosal delivery system attenuates intestinal inflammation in a mouse model Appl Environ Microbiol 74 7437-1052
[28]  
Behkam B(2018)Genetically engineered immunomodulatory Front Pharmacol 9 1354-408
[29]  
Scharf BE(2010) strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities Nat Rev Cancer 10 785-2926
[30]  
Buescher JM(2003)Evaluation of a Cancer Res 63 5188-835